Effects of synbiotic supplementation on clinical symptoms and metabolic outcomes in patients with painful diabetic neuropathy: a pilot randomized controlled trial

Diabetology & Metabolic Syndrome · Published 2026-08-05 · DOI 10.1186/s13098-026-02244-7

Free full text

Authors (3)

Manoochehr Amin Amlashi, Nahid Hashemi-Madani, Shima Jazayeri

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Amlashi, M., Hashemi-Madani, N., Jazayeri, S. (2026). Effects of synbiotic supplementation on clinical symptoms and metabolic outcomes in patients with painful diabetic neuropathy: a pilot randomized controlled trial. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-026-02244-7

Related articles

• Continuous glucose monitoring metrics based clustering in people living with type 1 diabetes identifies phenotypes associated with higher inflammation, metabolic dysfunction-associated steatotic liver disease risk, and lower insulin sensitivity · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Relationship between hs-CRP-triglyceride glucose index and coronary plaque morphology: insights from optical coherence tomography · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Dietary index for gut microbiota and risk of metabolic syndrome: the mediating role of hepatic steatosis in a prospective cohort study · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Effects of lifestyle education interventions on quality of life and fbg in women with gestational diabetes: a systematic review and meta-analysis · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Islet autoantibodies as predictors of type 1 diabetes development, a systematic review with public health implications for Africa · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Beyond TIR: the impact of technology on glucose variability in a cohort of preschool children with T1D · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Trajectories, cumulative burden of the dynamic triglyceride glucose-Chinese visceral adiposity index, and risk of incident cardiovascular diseases: a large prospective cohort study · Diabetology & Metabolic Syndrome · 2026 · Same journal
• A putative SGLT-relevant mechanistic perspective on quercetin-3-O-glucoside and rutin in diabetic kidney disease · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Prognostic value of estimated pulse wave velocity for all-cause and cardiovascular mortality in individuals with cardiovascular–kidney–metabolic (CKM) syndrome: analyses of NHANES 2007–2018 · Diabetology & Metabolic Syndrome · 2026 · Same journal
• Insulin pump therapy for T1D: a real-world analysis of a novel two-in-one insulin pump in Chinese adults with type 1 diabetes · Diabetology & Metabolic Syndrome · 2026 · Same journal